Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
Publication year
2019Source
Leukemia, 33, 8, (2019), pp. 2116-2120ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Physiology
Internal Medicine
Paediatrics
Pharmacology-Toxicology
Neurology
Laboratory Medicine
Haematology
Journal title
Leukemia
Volume
vol. 33
Issue
iss. 8
Page start
p. 2116
Page end
p. 2120
Subject
Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Radboudumc 6: Metabolic Disorders RIHS: Radboud Institute for Health Sciences; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227612]
- Electronic publications [107286]
- Faculty of Medical Sciences [86193]
- Open Access publications [76415]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.